mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-05 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-05 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-05 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-05 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-05 |